Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950159-13-000644
Filing Date
2013-12-02
Accepted
2013-12-02 17:20:47
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 TENGION 10-Q form10q.htm 10-Q 1818594
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 12726
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 13029
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8255
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 8982
  Complete submission text file 0000950159-13-000644.txt   9202585

Data Files

Seq Description Document Type Size
6 tngn-20130930.xml EX-101.INS 1504915
7 tngn-20130930.xsd EX-101.SCH 60424
8 tngn-20130930_cal.xml EX-101.CAL 44051
9 tngn-20130930_def.xml EX-101.DEF 226178
10 tngn-20130930_lab.xml EX-101.LAB 770031
11 tngn-20130930_pre.xml EX-101.PRE 377913
Mailing Address 3929 WESTPOINT BLVD. SUITE G WINSTON-SALEM NC 27103
Business Address 3929 WESTPOINT BLVD. SUITE G WINSTON-SALEM NC 27103 336-722-5855
TENGION INC (Filer) CIK: 0001296391 (see all company filings)

EIN.: 200214813 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34688 | Film No.: 131252483
SIC: 2836 Biological Products, (No Diagnostic Substances)